JP2013532130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532130A5 JP2013532130A5 JP2013510364A JP2013510364A JP2013532130A5 JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5 JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013510364 A JP2013510364 A JP 2013510364A JP 2013532130 A5 JP2013532130 A5 JP 2013532130A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- compound
- pharmaceutically acceptable
- acceptable salt
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33499110P | 2010-05-14 | 2010-05-14 | |
| US61/334,991 | 2010-05-14 | ||
| US37074510P | 2010-08-04 | 2010-08-04 | |
| US61/370,745 | 2010-08-04 | ||
| US37586310P | 2010-08-22 | 2010-08-22 | |
| US61/375,863 | 2010-08-22 | ||
| PCT/US2011/036701 WO2011143669A2 (en) | 2010-05-14 | 2011-05-16 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015049960A Division JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532130A JP2013532130A (ja) | 2013-08-15 |
| JP2013532130A5 true JP2013532130A5 (hr) | 2014-11-06 |
| JP5715241B2 JP5715241B2 (ja) | 2015-05-07 |
Family
ID=49052897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510364A Active JP5715241B2 (ja) | 2010-05-14 | 2011-05-16 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
| JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015049960A Active JP5937247B2 (ja) | 2010-05-14 | 2015-03-12 | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP5715241B2 (hr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011143651A1 (en) * | 2010-05-14 | 2011-11-17 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating metabolism |
| EP2902030B1 (en) | 2010-05-14 | 2016-09-14 | Dana-Farber Cancer Institute, Inc. | Thienotriazolodiazepine compounds for treating neoplasia |
| CA2877434A1 (en) * | 2012-06-25 | 2014-01-03 | Oncoethix Sa | Method of treating lymphoma using thienotriazolodiazepine compounds |
| WO2015018521A1 (en) * | 2013-08-06 | 2015-02-12 | Oncoethix Sa | Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor |
| US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
| WO2015131113A1 (en) | 2014-02-28 | 2015-09-03 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| MA42249A (fr) * | 2015-06-26 | 2018-05-02 | Tensha Therapeutics Inc | Traitement de carcinome de la ligne médiane nut |
| RU2750164C2 (ru) * | 2015-09-11 | 2021-06-22 | Дана-Фарбер Кэнсер Инститьют, Инк. | Цианотиенотриазолодиазепины и пути их применения |
| BR112018004617A2 (pt) * | 2015-09-11 | 2018-09-25 | Dana Farber Cancer Inst Inc | acetamida tienotriazoldiazepinas e usos das mesmas |
| EP3355922A2 (en) * | 2015-10-02 | 2018-08-08 | Dana Farber Cancer Institute, Inc. | Combination therapy of bromodomain inhibitors and checkpoint blockade |
| WO2017142881A1 (en) * | 2016-02-15 | 2017-08-24 | The Regents Of The University Of Michigan | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors |
| EP3555059A1 (en) * | 2016-12-16 | 2019-10-23 | H. Hoffnabb-La Roche Ag | Process for the manufacture of diazepine derivatives |
| CN109503618A (zh) * | 2017-09-14 | 2019-03-22 | 成都海创药业有限公司 | 一种brd4抑制剂 |
| MX2020013608A (es) * | 2018-06-13 | 2021-03-09 | Worg Pharmaceuticals Hangzhou Co Ltd | Preparacion de derivados de triazepina condensados y su uso como inhibidores de bet. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934940A1 (en) * | 1996-06-12 | 1999-08-11 | Japan Tobacco Inc. | Cytokine production inhibitors, triazepine compounds, and intermediates thereof |
| US7589167B2 (en) * | 2000-02-22 | 2009-09-15 | J. David Gladstone Institutes | ZA loops of bromodomains |
| MXPA05009151A (es) * | 2003-02-27 | 2005-10-20 | Abbott Lab | Inhibidores de cinasa heterociclica. |
| WO2009084693A1 (ja) * | 2007-12-28 | 2009-07-09 | Mitsubishi Tanabe Pharma Corporation | 抗癌剤 |
| WO2011054845A1 (en) * | 2009-11-05 | 2011-05-12 | Glaxosmithkline Llc | Benzodiazepine bromodomain inhibitor |
-
2011
- 2011-05-16 JP JP2013510364A patent/JP5715241B2/ja active Active
-
2015
- 2015-03-12 JP JP2015049960A patent/JP5937247B2/ja active Active